Financials

News Discussions Technicals Seasonals

2160 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to MICROPORT CARDIOFLOW MEDTECH CORP operating, investing, and financing activities

2160 free cash flow for H1 24 is -55.93 M HKD. For 2023, 2160 free cash flow was -249.77 M HKD and operating cash flow was -218.91 M HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—